physical labeling of papillomavirus-infected, immortal, and cancerous cervical epithelial cells...
TRANSCRIPT
ORIGINAL PAPER
Physical Labeling of Papillomavirus-Infected, Immortal,and Cancerous Cervical Epithelial Cells Reveal Surface Changesat Immortal Stage
K. Swaminathan Iyer • R. M. Gaikwad •
C. D. Woodworth • D. O. Volkov • Igor Sokolov
Published online: 17 February 2012
� Springer Science+Business Media, LLC 2012
Abstract A significant change of surface features of
malignant cervical epithelial cells compared to normal
cells has been previously reported. Here, we are studying
the question at which progressive stage leading to cervical
cancer the surface alteration happens. A non-traditional
method to identify malignant cervical epithelial cells in
vitro, which is based on physical (in contrast to specific
biochemical) labelling of cells with fluorescent silica
micron-size beads, is used here to examine cells at pro-
gressive stages leading to cervical cancer which include
normal epithelial cells, cells infected with human papillo-
mavirus type-16 (HPV-16), cells immortalized by HPV-16,
and carcinoma cells. The study shows a statistically sig-
nificant (at p \ 0.01) difference between both immortal
and cancer cells and a group consisting of normal and
infected. There is no significant difference between normal
and infected cells. Immortal cells demonstrate the signal
which is closer to cancer cells than to either normal or
infected cells. This implies that the cell surface, surface
cellular brush changes substantially when cells become
immortal. Physical labeling of the cell surface represents a
substantial departure from the traditional biochemical
labeling methods. The results presented show the potential
significance of physical properties of the cell surface for
development of clinical methods for early detection of
cervical cancer, even at the stage of immortalized, pre-
malignant cells.
Keywords Cervical cancer � Early cancer detection �Novel detection methods � Fluorescent silica particles
Introduction
Cervical cancer is the second most common cause of
cancer death in women worldwide; infection with onco-
genic human papillomavirus (HPV) is the most significant
risk factor in its etiology [1]. The mortality rate is second
only to that for breast cancer. Early detection of this cancer
can substantially decrease mortality due to this disease.
The demand to reduce the mortality related to cervical
cancer has resulted in inter-disciplinary research involving
physics, chemistry, molecular biology, engineering, and
medicine [2]. Research efforts over the years have been
directed toward the development of a universal, reliable,
and consistent test to detect malignant cells at the early
stages of cancer development, and in particular, prema-
lignant cervical cells, also known as cervical intraepithelial
neoplasia (CIN) [3].
Electronic supplementary material The online version of thisarticle (doi:10.1007/s12013-012-9345-2) contains supplementarymaterial, which is available to authorized users.
K. Swaminathan Iyer � R. M. Gaikwad �D. O. Volkov � I. Sokolov (&)
Department of Physics, Clarkson University, Potsdam,
NY 13699-5820, USA
e-mail: [email protected]
Present Address:K. Swaminathan Iyer
School of Biomedical, Biomolecular and Chemical Sciences,
The University of Western Australia, Crawley, WA, Australia
C. D. Woodworth
Department of Biology, Nanoengineering and Biotechnology
Laboratories Center (NABLAB), Clarkson University,
Potsdam, NY 13699-5820, USA
I. Sokolov
Nanoengineering and Biotechnology Laboratories Center
(NABLAB), Clarkson University, Potsdam,
NY 13699-5820, USA
123
Cell Biochem Biophys (2012) 63:109–116
DOI 10.1007/s12013-012-9345-2
HPV-associated cervical carcinogenesis is a multistep
process leading to the transformation of the infected cells
to CIN [3]. The cells associated with the lesions become
atypical and mitotically active, and they are characterized
by the inability to terminally differentiate [4]. Low grade
CIN are typically limited to the lower portion of the epi-
thelia, but they can progress to high-grade CIN and become
evident throughout the entire thickness of the epithelia and
eventually lead to cervical carcinoma. The multistep pro-
cess leading to transformation of infected cells to CIN is
associated with over expression of two early genes, E6 and
E7 [5, 6]. These genes are consistently expressed in cer-
vical cancer cell lines and involved in HPV-mediated
carcinogenesis [7]. The transforming ability of the genes is
partly due to their ability to interact with cellular tumor
suppressor proteins. E6 binds the tumor suppressor p53
through its interaction with another cellular protein, E6-
associated protein (E6-AP), leads to degradation of p53 via
the ubiquitin-mediated protein degradation pathway [8, 9].
E7 binds and degrades the retinoblastoma tumor suscepti-
bility gene product (pRb) and also the other pRb ‘‘pocket’’
protein family members, p107 and p130 [10, 11].
The Papanicolaou (Pap) smear, a cytological screening
test has been one of the most successful methods of cer-
vical cancer detection over the years [12]. Although the
Pap smear is the most widely used cancer screening
method in the world and its impact on the incidence of
cervical cancer is well known from a historical perspective,
recent reports suggest that the sensitivity of Pap smear
screening is 50–80%, with the relative proportion of sam-
pling to screening errors being 2:1 [13]. There are multiple
benign mimics of neoplastic cells such as atypia of repair,
atrophy, radiation change, effect of intrauterine device, and
metaplasia. These cells are called atypical cells of unde-
termined significance due to the inability of optical
microscopy to identify definite features of either benign or
neoplastic cells. The tests may be further complicated by
high-unsatisfactory rates, preparation artifacts, and unnec-
essary cost interventions. Each year in the United States
alone approximately 3.5 million Pap smears cytological
tests are classified as equivocal, out of which only 8% of
women will have preinvasive (high-grade squamous
intraepithelial) lesions, and 0.4% will have carcinoma as
found in further testing that involves invasive tissue biop-
sies. DNA tests (detection of HPV, human papillomavirus
infection) are rather accurate, but identify only a risk of
cancer (the fact of HPV infection) but not cancer [44].
The economic constraints in developing countries have
prompted alternative methods of screening for cancer
including visual inspection after application of 3–5% of
acetic acid [14] and Lugol’s iodine [15]. The major dis-
advantage of these tests is low specificity. Given the con-
siderable variation in the way these tests are applied and
interpreted in different settings, there is no standard uni-
versally accepted definition of the test results. It remains to
be seen if the specificity can be improved by further
developments in test definitions and training strategies. The
inability of these test methods to unambiguously detect
abnormal cells during the early stages, poses a major
challenge in an effort to reduce mortality associated with
cervical cancer.
Demands for the development of a universal testing and
screening method have generated enormous scientific and
industrial interest in the past. Several methods such as
organic receptor molecules that undergo color changes
[16], electrochemical, [17] magnetic [18], and fluorescent
tags [19, 20] have been developed and reported. Optical
techniques like fluorescent microscopy [21] confocal
imaging [22] and optical coherence tomography (OCT)
[23] have shown promise for cervical precancer detection
as measured against the traditional methods such a Pap
smear. The sensitivity and specificities of these optical
techniques have been reported to reach 80–90% in small
and moderate clinical trials [24].
Among the optical techniques, detection using fluores-
cence is an important non-isotopic method. The fluorescent
biological labels have played an important role in the field
of biomedicine, such as the detection of materials inside or
outside of the cell [25, 26], hybridization and sequencing of
nucleic acids [27], and clinical diagnosis at the early stage
[28]. These conventional fluorescent techniques have the
following limitations: reduction in the emission intensity
due to photobleaching, the toxicity of some of the fluo-
rescent dyes may be harmful for living cells, and detection
sensitivity is not so high because only a few fluorophores
can be coupled to one biomolecule in the conventional
fluorescent label methods.
It was recently found [29] that a several micron silica
particle attached to a cantilever of an atomic force micro-
scope [30] (AFM) interacted with cancerous and normal
cells quite differently. The main reason was attributed to a
different topological structure of surface ‘‘brushes’’ cov-
ering cells, which consisted of microvilli, microridges,
cilia, and glycocalyx molecules. Using that observation, a
new method to identify cervical cancer cells was suggested
[31, 32]. The method was based on the use of silica par-
ticles of similar size but fluorescent in nature. The differ-
ence in the cell brush resulted in the different adhesion of
the silica beads-cell. Furthermore, a high-resolution mul-
timodal AFM imaging in novel HarmoniX mode revealed
virtually 100% difference between the surface of normal
and cancerous cells [43]. This AFM method was very
precise but rather slow. In addition, the detection of pre-
malignant (immortal) cells is more interesting for potential
clinical early diagnosis of cancer. Thus, it is important to
test if the faster labeling method Ref. [31] could potentially
110 Cell Biochem Biophys (2012) 63:109–116
123
be effective in the defection of immortal cells. From the
fundamental point of view, it is informative to learn the
stage of cancer progression when the cell surface starts
changing.
In this study, we use the fast method of Ref. [31] to
study cervical cells during the different stages of multistep
transformation leading from normal to cancer. Specifically,
we study normal, infected (with HPV-16), immortal, and
cancerous cells. Here we confirm previous results for
normal and cancerous cervical cells [31], and find that in
the progression leading to cervical cancer, adhesion (or cell
surface) changes significantly at the stage of immortal
cells. We found that cancerous and immortal cells (the
latter were derived from HPV-infected cells) adhere to
silica beads in a statistically different manner than normal
cells and HPV-infected cells.
Materials and Methods
Spectrofluorometric Measurements and Imaging
of Cells
A scheme of the experimental setup is shown in Fig. 1. An
Olympus BH2-UMA microscope, which works in both
transmission and reflection mode, was connected to a JVC
TK-1280U color video camera. The images of cells were
captured using FlashBus MV version 3.91 software. To
record the fluorescent emission, an optic fiber was used to
connect the microscope to an spectrometer (USB 2000 by
Ocean Optics Inc., FL). A Cyonics air-cooled argon ion
laser was used as an excitation source for fluorescence. A
narrow-band 488 nm blocking filter (Omega Optical) was
utilized to filter the laser light. The spectra were recorded
using OOIBase32 software. To avoid excessive focusing on
individual florescent particles, and consequent collecting
the emission spectra from excessively those particles, after
the focusing, the focus knob was rotated three full turns in
counter clockwise direction (defocusing the sample by
increasing the sample-objective lens distance). This pro-
cedure was maintained constant for spectrofluorometric
measurements of all samples. 59 objective was used in
these measurements. This allowed collecting the fluores-
cent signal coming from a predefined area of approxi-
mately 4 mm in diameter (as was found by moving
individual fluorescent beads).
To decrease possible dependency of the fluorescent
signal on the device used, the spectrometer was calibrated
with the help of LS-1 Tungsten Halogen Light Source
(USB 2000 by Ocean Optics Inc., FL) by using the pro-
cedure described by the manufacturer. To decrease the
noise, each fluorescent signal used in this study was an
integral of the fluorescent intensities (taken in the range of
560–680 nm).
Statistical analysis was done with the help of Origin 8
software (Origin Labs). The significance of statistical dif-
ference was analysed with ANOVA test using the confi-
dence level of p of 0.01. Specifically, one-way ANOVA
using the Tukey test of mean comparisons was used. Equal
variances of distributions were verified using Levene’s
tests.
Cell Cultures
Primary cultures of human cervical epithelial cells were
prepared by a two-stage enzymatic digestion of cervical
tissue as described [33] In brief, each tissue was digested
for 16 h at 4�C in dispase and the layer of epithelial cells
was removed from the underlying connective tissue by
scraping. The sheet of epithelial cells was cut into 1 mm2
pieces and digested in 0.25% trypsin at 37�C for 10 min.
Trypsin was neutralized by adding fetal bovine serum and
cells were collected by low-speed centrifugation. Cultures
consisting of C95% epithelial cells were maintained in
keratinocyte serum-free medium (Invitrogen) which pre-
vents outgrowth of fibroblasts and other stromal cells.
HPV-16 immortalized cell lines [41] and cervical carci-
noma cell lines [42] were also maintained in KSFM and no
evidence of contamination by fibroblasts or other stromal
cells was observed.
All human tissue was obtained from the Cooperative
Human Tissue Network. Informed consent was obtained
from patients according to their published guidelines
(http://chtn.nci.nih.gov/phspolicies.html). The transforma-
tion of normal cells in precancerous squamous intraepi-
thelial lesions is associated with over expression of the E6
and E7 genes. HPV genes were introduced into cultured
cervical cells by infection with recombinant retrovirusesFig. 1 (Color online) Schematic diagram of the optical measurement
system
Cell Biochem Biophys (2012) 63:109–116 111
123
encoding HPV-16 E6/E7 genes inserted into the vector
pLXSN, which contains the neomycin resistance gene [34].
Infection (MOI = 10) was performed for 3 h in medium
with 10 ng/ml polybrene with rocking every 15 min.
Subsequently, medium was changed and cells grew for
24 h before cultures were split 1:3. After 24 h, infected
cells were selected by growth for 2 days in KSFM con-
taining 200 lg/ml G418 and used immediately. Approxi-
mately 70–90% of cells were infected as determined by
survival after G418 selection.
Normal cervical cells were used between 40 and 60
population doublings (PDs), and carcinoma cell lines were
used at 90–120. The slightly higher number of PDs for
cancer cell lines avoids potential confusion because any
normal cells (epithelial cells or stromal cells) that may
contaminate the cancer culture dishes would die out by that
number of PDs. This allows us to avoid possible confusion
between cancer cells and either normal epithelial cells or
fibroblasts. All cells were plated in 60 mm tissue culture
dishes and dishes were used for experiments when cells
were 80–100% confluent.
Fluorescent Silica Beads
Recently a new one step self-assembly of nanoporous silica
particles with encapsulated organic dyes has been devel-
oped, [35–37] in which the dyes are physically entrapped
inside silica matrix, inside 2–4 nm in diameter nanochan-
nels. It was found that the synthesized particles could be up
to two orders of magnitude brighter than the micron-size
particles assembled from aqueous dispersible quantum dots
[38] encapsulated in polymeric particles (scaled to the
same size). Comparing with the maximum fluorescence of
free dye in the same volume, the particles can show fluo-
rescence which is higher by a factor of *5,000. This
makes the particles the brightest tags presently available.
The synthesis of these particles is described in the cor-
responding references. In brief, it is a one step synthesis.
Tetraethylorthosilicate (TEOS, 99.99?%, Aldrich), cetyl-
trimethylammonium chloride (CTACl, 25 wt% aqueous
solution, Pflatz & Bauer), formamide (99%, Aldrich) and
hydrochloric acid HCl (37.6 wt% aqueous solution, Safe-
Cote), Rhodamine 640 (R40) dye (Sigma-Aldrige, Inc.)
were used. All chemicals were used as received. The sur-
factant, acid, dye, formamide, and distilled water (Corning,
AG-1b, 1 MX-cm) were stirred in a polypropylene bottle at
room temperature for 2 h, after which TEOS was added
and the solution stirred for ca. 5 min. The solution was then
kept under quiescent conditions for 3 days. The molar ratio
of H2O:HCl:formamide:CTACl:R6G:TEOS was 100:7.8:
9.5:0.11:0.01:0.13. The materials that formed were washed
by centrifugation to avoid damaging of the surface, washed
with copious amounts of water (till the leakage of the dye
stops), and mixed with HBSS solution for the further use
on the cell culture.
Detection of Affinity of Fluorescent Silica Beads
to Cells
After carefully washing the particles to remove any traces
of the synthesizing chemistry, the particles were added to
Hanks balanced salt solution (HBSS) at a pH of 7.4 to form
a colloidal dispersion (*2 g/l). The cells in the 60 mm
culture dishes were washed twice with HBSS solution for
2 min each. The cells were then exposed to 1 ml of the
colloidal dispersion for 2 min. During this 2 min period,
the dishes were subjected to initial 30 s of shaking on a
Boekel Scientific Ocelot 260300F at minimum speed, to
insure uniform distribution of the colloidal solution and to
minimize particle agglomeration. To remove excess parti-
cles that had not adhered to the cells, the cells were then
washed with HBSS solution two times thoroughly using the
same Boekel shaker. The culture dishes were then dried
under ambient conditions at room temperature.
It is important to note the density of cells in the culture
dish. The measurements were done on cells that just reached
confluency in the cell culture dish bottom. This allows us to
exclude the possible affinity of the particles to the culture
dish bottom as well as dealing with different total areas of
coverage of cells in different dishes. In this case, the pro-
cessing of the results becomes simple because the amount
of adherent fluorescent particles is linearly proportional to
the fluorescent signal. The analysis of cells that are far from
confluency is possible [30] although this requires more
processing time or development of a special software.
Results
Figure 2 shows representative optical images (combined
fluorescence and transmission microscopy) of particles that
adhered to the surface of normal, HPV-16 infected,
immortal, and cancerous cells. One can see higher amounts
of particles adherent to cancer and immortal cell surfaces
as compared to normal and infected cells. To describe this
difference quantitatively, we measured fluorescence for
each type of cell. On average, the fluorescent signal
(measured as described in the Materials and Methods
section) is proportional to the number of fluorescent silica
beads adherent to the cell surfaces. Therefore, the fluo-
rescent signal is a good measure of the difference in
adhesion of fluorescent silica beads to the cells.
Figure 3 shows the fluorescent signals of silica beads
measured on culture dishes containing either normal, or
HPV-16 infected, or immortal, or cancerous cells. Indi-
vidual fluorescent spectra and their integral used to obtain
112 Cell Biochem Biophys (2012) 63:109–116
123
the data presented in Fig. 3 are shown in the Supplemen-
tary Materials (Figure S1 and Table S1). Each cell type was
derived from tissues of three human subjects, and was
tested using three culture dishes, 10–20 readings per dish
(5–6 fluorescent spectra averaged over three measurements
each). Figure 3a shows the total statistical data of fluo-
rescence for all human subjects. The average and one
standard deviation are shown. Figure 3b presents the sta-
tistical fluorescence data for each human subject sepa-
rately. The average, one standard deviation and minimum/
maximum are shown (details of the data are provided in the
Supplementary Materials).
One can see an insignificant difference in the fluores-
cence signals from the silica beads adherent on normal and
infected cells. Statistical analysis shows that the difference
in the values of these intensities is statistically insignificant
at the confidence level of 0.01.
Comparing the fluorescence data of the immortal cells
with that of the normal and infected cells, one can see a
difference. It is evident that the fluorescent intensity is
stronger in the case of immortal cells, and getting closer to
that of cancerous cells. Statistical analysis shows that the
fluorescent signal collected from immortal cells is signifi-
cantly different from the signals collected on either normal
or infected cells at the confidence level p \ 0.01.
The same statistically significant difference at the con-
fidence level p \ 0.01 was found for the cancerous cells
compared to the normal, infected cells, and even immortal
cells. However, the fluorescent signals coming from the
silica beads that adhered to cancer cells were noticeably
less different from that of the immortal cells when com-
pared to that of either normal or infected cells (see, the
values of probability and q-value in Table S4; further
details of the statistical analysis are shown in the Supple-
mentary Materials (Tables S2–S4).
To summarize, our results show a statistically significant
(at p \ 0.01) difference between all types of cells except
normal-infected consisting of normal and infected and a
group of immortal and cancer cells. This implies that the
cell surface changes substantially when cells become
immortal in its progression to cancer.
Discussion
Here we study the change of the surface of human cervical
epithelial cells during this progression to cancer, from
normal, to HPV-infected, to immortal, and then to the
carcinoma stage. Such a change has previously been
reported when comparing normal and cancerous epithelial
cervical cells [29, 31, 32], and was attributed to the change
of microvilli content of the cellular brush. Physical
adsorption of fluorescent silica beads is used to monitor the
change of cell surface, the method described in Ref. [31].
Fig. 2 (Color online)
2009110 lm2 optical images of
normal, infected, immortal, and
cancer cells with fluorescent
silica particles attached. The
cells are seen as an almost
continuous (green) background,
and the particles are the bright
spots (red)
Cell Biochem Biophys (2012) 63:109–116 113
123
Visual inspection of the optical images (Fig. 2) shows that
the number of particles adsorbed on the cancer and
immortal cell surfaces is typically more than that on the
normal and infected cell surface. The quantitative mea-
surements of fluorescent signal coming from the fluores-
cent silica beads adherent to the cell surface, Fig. 3a),
confirms this observation statistically with the confidence
level of 0.01.
Figure 3b shows a noticeable variability of the fluores-
cent signals collected from different human subjects. While
this variability does not change the conclusion of the
alteration of the cell surface starting from the stage of
immortalization, this implies the need for studying more
human subjects if this method is going to be used for
diagnostic purposes.
To determine whether the presence of E6 and E7 genes
alters the cell surface (and consequently, the number of
silica particles adsorbed to the cell surface), we compared
the fluorescence signal coming from the silica beads
adhered to normal and infected cells. Because the fluo-
rescence signals from normal and infected cells were
statistically similar (the difference was statistically insig-
nificant at the confidence level p \ 0.01), one could con-
clude that the infected cells have surface characteristics
similar to normal cells. From this we can conclude that just
the presence of E6 and E7 genes is not sufficient to change
the cell surface.
It was reported that the two genes E6 and E7 have to act
synergistically to induce cell immortalization [4]. It was
speculated that E7 can prolong the lifespan of cells and
therefore, supposedly induce overgrowth of cells. How-
ever, E7 can also induce apoptosis [39]. E6 inhibits the
apoptosis induced by E7, accentuating the effects of E7 on
immortalization [40]. Synergistic action of the oncogenes
is a progressive time-dependent process. From this we can
conclude that the synergistic action of both E6 and E7
genes alone is not sufficient to change the cell surface. One
can see that the fluorescent signal is stronger in the case of
immortal cells, and getting closer to cancerous cells. It is
also in agreement with in vivo results of Ref. [41] in which
it was shown that immortal cells of similar passages used
here behaved more as cancerous cells. In addition, the
observed difference between normal and cancer cells is in
agreement with the data reported previously [29].
To amplify, we showed that the cell surface changes
substantially at the stage of immortalization. This implies
direct correlation between the increased adhesion and
expression of both E6 and E7 genes. In the light of results
of Ref. [29], it presumably means that the cellular brush
(microvilli, microridges, glycocalyx, etc.) alters substan-
tially when cells become immortal. Second, our results
showed that the physical labeling of cervical epithelial cells
with fluorescent silica beads could be suitable for dis-
crimination of both immortal and cancerous cervical cells
in a culture dish. This demonstrates the significance of
physical properties of the cell surface for the development
of clinical methods for early detection of cervical cancer,
even at the stage of immortalized premalignant cells. Such
detection would represent a substantial departure from the
traditional biochemically specific labeling methods.
Acknowledgments Funding for this study from the National Sci-
ence Foundation NSF CBET 0755704 and ARO W911NF-05-1-0339
(I.S.) and the National Cancer Institute 1R15CA126855-01 (C.W.) are
acknowledged. Human tissue was obtained from the Cooperative
Human Tissue Network.
Conflict of interest The authors have no conflicts of interest to
declare.
Fig. 3 The fluorescent signals collected from silica beads adhered to
cells taken from three healthy individuals, three cell stains infected
with HPV-16 virus (derived from cells of three healthy individuals),
three immortal cell lines (derived from three cell stains infected with
HPV-16 virus), and malignant cells from three cancer patients. a The
averaged fluorescent signal for all human subjects and one standard
deviation are shown in the graph. b The average (middle line in the
box), one standard deviation (the box) and minimum/maximum
(error-bar markers) are shown for each human subject separately
114 Cell Biochem Biophys (2012) 63:109–116
123
References
1. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X.,
Kummer, J. A., Shah, K. V., et al. (1999). Human papillomavirus
is a necessary cause of invasive cervical cancer worldwide.
Journal of Pathology, 189, 12–19.
2. Sprintz, M. (2004). Editorial: Nanotechnology for advanced
therapy and diagnosis. Biomedical Microdevices, 6, 101–103.
3. Wright, T. C., Kurman, R. J., & Ferenczy, A. (1994). In R. J. Kurman
(Ed.), Precancerous lesions of the cervix in Blaustein’s pathology ofthe female genital tract (pp. 229–278). New York: Springer-Verlag.
4. Song, S., Liem, A., Miller, J. A., & Lambert, P. F. (2000). Human
papillomavirus types 16 E6 and E7 contribute differently to
carcinogenesis. Virology, 267, 141–150.
5. Cooper, K., Herrington, C. S., Lo, E. S., Evans, M. F., & McGee,
J. O. (1992). Integration of human papillomavirus types 16 and
18 in cervical adenocarcinoma. Journal of Clinical Pathology,45, 382–384.
6. Daniel, B., Rangarajan, A., Mukherjee, G., Vallikad, E., &
Krishna, S. (1997). The link between integration and expression
of human papillomavirus type 16 genomes and cellular changes
in the evolution of cervical intraepithelial neoplastic lesions.
Journal of General Virology, 78(Pt 5), 1095–1101.
7. von Knebel Doeberitz, M., Oltersdorf, T., Schwarz, E., &
Gissmann, L. (1988). Correlation of modified human papilloma
virus early gene expression with altered growth properties in
C4–1 cervical carcinoma cells. Cancer Research, 48, 3780–3786.
8. Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991).
A cellular protein mediates association of p53 with the E6
oncoprotein of human papillomavirus types 16 or 18. EMBOJournal, 10, 4129–4135.
9. Werness, B. A., Levine, A. J., & Howley, P. M. (1990). Asso-
ciation of human papillomavirus types 16 and 18 E6 proteins with
p53. Science, 248, 76–79.
10. Dyson, N., Guida, P., Munger, K., & Harlow, E. (1992).
Homologous sequences in adenovirus E1A and human papillo-
mavirus E7 proteins mediate interaction with the same set of
cellular proteins. Journal of Virology, 66, 6893–6902.
11. Jones, D. L., Thompson, D. A., & Munger, K. (1997). Destabi-
lization of the RB tumor suppressor protein and stabilization of
p53 contribute to HPV type 16 E7-induced apoptosis. Virology,239, 97–107.
12. Nuovo, J., Melnikow, J., & Howell, L. P. (2001). New tests for
cervical cancer screening. American Family Physician, 64,
780–786.
13. Monsonego, J., Bosch, F. X., Coursaget, P., Cox, J. T., Franco, E.,
Frazer, I., et al. (2004). Cervical cancer control, priorities and
new directions. International Journal of Cancer, 108, 329–333.
14. Belinson, J. L., Pretorius, R. G., Zhang, W. H., Wu, L. Y., Qiao,
Y. L., & Elson, P. (2001). Cervical cancer screening by simple
visual inspection after acetic acid. Obstetrics and Gynecology,98, 441–444.
15. Bhatla, N., Mukhopadhyay, A., Joshi, S., Kumar, A., Kriplani, A.,
Pandey, R. M., et al. (2004). Visual inspection for cervical cancer
screening: Evaluation by doctor versus paramedical worker.
Indian Journal of Cancer, 41, 32–36.
16. Marcelli, M., Ittmann, M., Mariani, S., Sutherland, R., Nigam, R.,
Murthy, L., et al. (2000). Androgen receptor mutations in prostate
cancer. Cancer Research, 60, 944–949.
17. Scarcigilia, L., Compagnone, D., Fedrici, G., & Palleschi, G.
(1998). Electrochemical probe for polyamines detection in bio-
logical fluids. Analysis, 26, 219–222.
18. Adamek, H. E., Albert, J., Breer, H., Weitz, M., Schilling, D., &
Riemann, J. F. (2000). Pancreatic cancer detection with magnetic
resonance cholangiopancreatography and endoscopic retrograde
cholangiopancreatography: A prospective controlled study. Lan-cet, 356, 190–193.
19. Fodor, S. P., Rava, R. P., Huang, X. C., Pease, A. C., Holmes, C.
P., & Adams, C. L. (1993). Multiplexed biochemical assays with
biological chips. Nature, 364, 555–556.
20. Weissleder, R., Tung, C. H., Mahmood, U., & Bogdanov, A., Jr.
(1999). In vivo imaging of tumors with protease-activated near-
infrared fluorescent probes. Nature Biotechnology, 17, 375–378.
21. Ramanujam, N., Mitchell, M. F., Mahadevan-Jansen, A., Thomsen,
S. L., Staerkel, G., Malpica, A., et al. (1996). Cervical precancer
detection using a multivariate statistical algorithm based on laser-
induced fluorescence spectra at multiple excitation wavelengths.
Photochemistry and Photobiology, 64, 720–735.
22. Drezek, R. A., Collier, T., Brookner, C. K., Malpica, A., Lotan, R.,
Richards-Kortum, R. R., et al. (2000). Laser scanning confocal
microscopy of cervical tissue before and after application of
acetic acid. American Journal of Obstetrics and Gynecology, 182,
1135–1139.
23. Pitris, C., Goodman, A., Boppart, S. A., Libus, J. J., Fujimoto, J. G.,
& Brezinski, M. E. (1999). High-resolution imaging of gyneco-
logic neoplasms using optical coherence tomography. Obstetricsand Gynecology, 93, 135–139.
24. Mitchell, M. F., Cantor, S. B., Ramanujam, N., Tortolero-Luna, G.,
& Richards-Kortum, R. (1999). Fluorescence spectroscopy for
diagnosis of squamous intraepithelial lesions of the cervix.
Obstetrics and Gynecology, 93, 462–470.
25. Bui, J. D., Zelles, T., Lou, H. J., Gallion, V. L., Phillips, M. I., &
Tan, W. (1999). Probing intracellular dynamics in living cells
with near-field optics. Journal of Neuroscience Methods, 89,
9–15.
26. Tan, W., Parpura, V., Haydon, P. G., & Yeung, E. S. (1995).
Neurotransmitter imaging in living cells based on native fluo-
rescence detection. Analytical Chemistry, 67, 2575–2579.
27. Fung, J. C., Marshall, W. F., Dernburg, A., Agard, D. A., &
Sedat, J. W. (1998). Homologous chromosome pairing in Dro-
sophila melanogaster proceeds through multiple independent
initiations. Journal of Cell Biology, 141, 5–20.
28. Bornhop, D. J., Griffin, J. M., Goebel, T. S., Sudduth, M. R., Bell,
B., & Motamedi, M. (2003). Luminescent lanthanide chelate
contrast agents and detection of lesions in the hamster oral cancer
model. Applied Spectroscopy, 57, 1216–1222.
29. Iyer, S., Gaikwad, R. M., Subba-Rao, V., Woodworth, C. D., &
Sokolov, I. (2009). Atomic force microscopy detects differences
in the surface brush of normal and cancerous cells. NatureNanotechnology, 4, 389–393.
30. Sokolov, I., Iyer, S., & Woodworth, C. D. (2006). Recovery of
elasticity of aged human epithelial cells in vitro. Nanomedicine,2, 31–36.
31. Iyer, S., Woodworth, C. D., Gaikwad, R. M., Kievsky, Y. Y., &
Sokolov, I. (2009). Towards nonspecific detection of malignant
cervical cells with fluorescent silica beads. Small, 5, 2277–2284.
32. Gaikwad, R. M., Dokukin, M. E., Iyer, K. S., Woodworth, C. D.,
Volkov, D. O., & Sokolov, I. (2011). Detection of cancerous
cervical cells using physical adhesion of fluorescent silica parti-
cles and centripetal force. Analyst, 136, 1502–1506.
33. Woodworth, C. D., Doniger, J., & DiPaolo, J. A. (1989).
Immortalization of human foreskin keratinocytes by various
human papillomavirus DNAs corresponds to their association
with cervical carcinoma. Journal of Virology, 63, 159–164.
34. Woodworth, C. D., Cheng, S., Simpson, S., Hamacher, L., Chow,
L. T., Broker, T. R., et al. (1992). Recombinant retroviruses
encoding human papillomavirus type 18 E6 and E7 genes stim-
ulate proliferation and delay differentiation of human keratino-
cytes early after infection. Oncogene, 7, 619–626.
35. Cho, E. B., Volkov, D. O., & Sokolov, I. (2010). Ultrabright
fluorescent mesoporous silica nanoparticles. Small, 6, 2314–2319.
Cell Biochem Biophys (2012) 63:109–116 115
123
36. Sokolov, I., Kievsky, Y. Y., & Kaszpurenko, J. M. (2007). Self-
assembly of ultrabright fluorescent silica particles. Small, 3,
419–423.
37. Naik, S. P., & Igor, S. (2008). Ultra-bright fluorescent silica
particles: physical entrapment of fluorescent dye rhodamine 640
in nanochannels. In R. Nagarajan (Ed.), Nanoparticles: Synthesis,stabilization, passivation and functionalization (pp. 214–224).
London: ACS.
38. Han, M., Gao, X., Su, J. Z., & Nie, S. (2001). Quantum-dot-
tagged microbeads for multiplexed optical coding of biomole-
cules. Nature Biotechnology, 19, 631–635.
39. Pan, H., & Griep, A. E. (1994). Altered cell cycle regulation in
the lens of HPV-16 E6 or E7 transgenic mice: Implications for
tumor suppressor gene function in development. Genes andDevelopment, 8, 1285–1299.
40. Pan, H., & Griep, A. E. (1995). Temporally distinct patterns of
p53-dependent and p53-independent apoptosis during mouse lens
development. Genes and Development, 9, 2157–2169.
41. Woodworth, C. D., Waggoner, S., Barnes, W., Stoler, M. H., &
DiPaolo, J. A. (1990). Human cervical and foreskin epithelial
cells immortalized by human papillomavirus DNAs exhibit dys-
plastic differentiation in vivo. Cancer Research, 50, 3709–3715.
42. Woodworth, C. D., McMullin, E., Iglesias, M., & Plowman, G. D.
(1995). Interleukin 1 alpha and tumor necrosis factor alpha
stimulate autocrine amphiregulin expression and proliferation of
human papillomavirus-immortalized and carcinoma-derived cer-
vical epithelial cells. Proceedings of the National Academy of theSciences of the United States of America, 92, 2840–2844.
43. Dokukin, M. E., Guz, N. V., Gaikwad, R. M., Woodworth, C. D.,
& Sokolov, I. (2011). Cell surface as a fractal: Normal and
cancerous cervical cells demonstrate different fractal behavior of
surface adhesion maps at the nanoscale. Physical Review Letters,107, 028101.
44. Katki, H. A., & Wentzensen, N. (2012). How might HPV testing
be integrated into cervical screening? The lancet Oncology, 13,
8–10.
116 Cell Biochem Biophys (2012) 63:109–116
123